Join the 200th Anniversary Celebration

Issue IndexA searchable index of tables of contents

Find An Issue

By Volume and Issue
By Date

Table of contents for

June 23, 2005  Vol. 352 No. 25

Perspective
2571-2573

As of May 26, 2005, the Angolan Ministry of Health had reported 399 cases of Marburg hemorrhagic fever, 335 of which were fatal. Dr. C.J. Peters explains that our progress in understanding the filoviruses has been slow because of their rare appearance in ...

2573-2576

Dr. Jerry Avorn writes that the current trial designs may not optimally meet the scientific needs of prescribers, the clinical needs of patients, the economic needs of payers, or the regulatory needs of policymakers. But they superbly meet the business ...

2576-2578

In May, the Government Reform Committee of the U.S. House of Representatives held a hearing that explored how drugs with serious safety issues can remain so popular for so long. Representative Henry Waxman describes how what was learned illuminated the ...

2578-2580

Although the debate over the safety of NSAIDs continues, thousands of more circumscribed — and more urgent — debates take place every day in the offices of physicians. Dr. Nancy Olsen states that our patients need advice now, and their concerns cannot be ...

Original Articles
2581-2588

After myocardial infarction, the risk of sudden death is greatest in the first month and declines thereafter. Patients with an ejection fraction of 30 percent or less are at especially high risk for sudden death, though patients with a higher ejection fraction are still at increased risk. These data will help target preventive strategies to those at highest risk.

2589-2597

In early non–small-cell lung cancer, the standard of care is complete resection followed by observation. This large trial compared observation with adjuvant chemotherapy (vinorelbine plus cisplatin) in early-stage non–small-cell lung cancer and found that survival was improved by the addition of postoperative chemotherapy.

2598-2608

This multicenter, phase 2, placebo-controlled trial involved the use of a humanized antibody — ChAglyCD3 — directed against CD3 in the treatment of new-onset type 1 diabetes mellitus. Patients received placebo or ChAglyCD3 for 6 consecutive days and were then followed for 18 months. The insulin dose increased in patients treated with placebo but not in those treated with ChAglyCD3, and residual beta-cell function appeared to be relatively well preserved with ChAglyCD3. This approach may offer a new strategy for the preservation of residual pancreatic function in persons with newly diagnosed type 1 diabetes.

2609-2617

Patients with hepatitis C virus (HCV) genotype 2 or 3 were randomly assigned to a standard 24-week course of peginterferon and ribavirin or to therapy of variable duration, in that patients whose condition responded after 4 weeks were treated for 12 weeks rather than 24. The variable-duration strategy was associated with similar response and fewer side effects. This study suggests that a 12-week course of therapy is sufficient for patients with a response after 4 weeks of treatment.

Review Article
2618-2626

About 20 percent of ischemic strokes involve the posterior circulation. The correct diagnosis is often delayed, and workups in patients with symptoms may not always suggest vertebrobasilar disease. This review explains the causes, typical presentations, and characteristic findings of common strokes resulting from disease in the vertebral, basilar, or posterior cerebral arteries. Recommendations are made for treatment with thrombolytic agents and the prophylactic use of antiplatelet agents or anticoagulants.

Images in Clinical Medicine
2627
  • Free Full Text

A 38-year-old woman presented with increasing abdominal fullness and a new rash on the lower extremities. She had a history of chronic hepatitis C infection, for which she had been treated with interferon alfa several years earlier. She had a remote ...

e23
  • Free Full Text

This 35-year-old man was brought to the hospital on December 26, 2004. He had inhaled seawater when he nearly drowned. He had sinus discomfort but no difficulty breathing.

Case Records of the Massachusetts General Hospital
2628-2636

A 17-year-old Indonesian girl was swept up by a tsunami that followed a large earthquake. She aspirated salt water and mud but did not lose consciousness. Two days later, a cough developed; two weeks after the tsunami, she had headache, nausea, and vomiting. One week later, right-sided hemiparesis and aphasia developed, which worsened after several weeks in local hospitals. She was transferred to the U.S. Naval Ship Mercy for evaluation and treatment.

Editorials
2638-2640

Although the age-adjusted mortality from cardiovascular disease has declined in recent years, the number of sudden deaths has risen.1 According to data from the Centers for Disease Control and Prevention, 63 percent of deaths from cardiovascular causes in ...

2640-2642

Lung cancer has been the most common cancer in the world since 1985 and is today the leading cause of cancer-related death. In 2002, there were 1.35 million new cases and 1.18 million related deaths worldwide.1 Non–small-cell lung cancer, the most common ...

2642-2644

During the ominous prelude to the onset of type 1 diabetes, the pancreatic-islet beta cells become the targets of a specific autoimmune attack, which ultimately results in diabetes. Although major advances have led to an improved understanding of this ...

Clinical Implications of Basic Research
2645-2646

A recent study provides insight into the way in which Ebola virus enters cells and may therefore suggest a new strategy for therapy.

Correspondence
2647-2648

To the Editor: Sabatine et al. (March 24 issue)1 demonstrated in the Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)–Thrombolysis in Myocardial Infarction (TIMI) 28 trial that clopidogrel added to aspirin, heparin, and thrombolytic therapy for ...

2648-2650

To the Editor: Solomon et al., for the Adenoma Prevention with Celecoxib (APC) Study Investigators (March 17 issue),1 reported an increase in cardiovascular events associated with the use of celecoxib, and two accompanying editorials2,3 supported the ...

2650-2651

To the Editor: The cleverly designed and carefully conducted crossover trial reported by Gilron et al. (March 31 issue)1 shows better control of neuropathic pain with the combination of morphine and gabapentin than with single agents or placebo. Although ...

2651-2653
  • Free Full Text

To the Editor: DePalma et al. (March 31 issue)1 review four patterns of injuries from explosions and offer protocol for evaluating blast injuries that is based on the presence or absence of ruptured tympanic membranes. However, as suggested in the ...

2653

To the Editor: In late 2004, a “boxed warning” was added to the labeling for promethazine hydrochloride (Phenergan), including a contraindication for use in children less than two years of age and a strengthened warning with regard to use in children two ...

2654-2655

To the Editor: The tsunami that struck the Asian subcontinent and Africa on December 26, 2004, caused the deaths of more than 200,000 people. In Thailand more than 10,000 people were treated in ambulatory health centers. After a tsunami, the effects on ...

Book Reviews
2656

This unique book is the first serious attempt to correlate state-of-the-art radiologic images of the entire body with the underlying pathology. The contributors include recognized investigators in 12 European countries and the United States. The book was ...

2657
  • Free Full Text

Despite advances in the diagnosis, treatment, and understanding of the causes of skin cancer, the incidence of cutaneous neoplasms continues to increase: there were more than 1.3 million reported cases in the United States in 2004. It is now estimated ...

2657-2658

Transplantation has been a miracle of modern medicine. The success of transplantation of all solid organs began with the pioneers of kidney transplantation, who developed, tested, and refined innovative immunosuppressive treatment. In the early years, the ...

Trends: Most Viewed (Last Week)

More Trends